Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02141022 · ClinicalTrials.gov registry record · NA

Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya

A NA study, sponsored by Stony Brook University.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT02141022: Completed NA study, sponsored by Stony Brook University.

NCT02141022 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02141022, a NA study, has completed, sponsored by Stony Brook University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This study is investigating the efficacy of computer-based cognitive exercises as a means of cognitive remediation in patients with Multiple Sclerosis (MS) who are beginning the disease modifying pharmacotherapy Gileyna.

Interventions

  • OTHER plasticity-based computerized cognitive remediation program
  • DRUG Gileyna

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-08
Est. Completion 2015-09
Phase NA
Stony Brook University

127 total trials

What the finished NCT02141022 record still lists

NCT02141022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which plasticity-based computerized cognitive remediation program is the first listed.

NCT02141022 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02141022 about?

NCT02141022 is a clinical study titled "Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya". This study is investigating the efficacy of computer-based cognitive exercises as a means of cognitive remediation in patients with Multiple Sclerosis (MS) who are beginning the disease modifying pharmacotherapy Gileyna.

What is the current status of trial NCT02141022?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-08. Estimated completion is 2015-09.

What interventions are being tested in trial NCT02141022?

The interventions under investigation include: plasticity-based computerized cognitive remediation program (OTHER), Gileyna (DRUG).

Who is sponsoring clinical trial NCT02141022?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02141022's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02141022, the US trial registry maintained by the National Library of Medicine. NCT02141022 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.